vaccine available
Ebolavirus Zaire Vaccine
vaccine evaluation
vaccine candidate
ChAd3-EBO Z vaccine
clinical development
innovative vaccine technology
clinical study centers
clinical study data
true number of cases
total number of cases
affected countries of Guinea
GSK chimpanzee adenovirus type
current outbreak of Ebola virus disease
Disease Control
Sierra Leone
frontline health care workers
West Africa
early stage of development
Liberia
World Health Organization
US Centers
complete Phase
effective Ebola interventions
effect of booster vaccination
immunological effects of vaccination
containment of EBOV outbreaks
complex logistical challenges
significant time pressure
Prevention states
children
EVD
testing
adults
license
Nigeria
Senegal
EbolaVac
appropriate quality standards
capacity
Lausanne
Switzerland
risk
times higher
WP4
account
innovation
WP3
days
WP5
coordinated efforts
program
WP2
percent of fatalities
epidemic
deaths
project